Rml Mehrotra Pathology Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-10-2024
- Paid Up Capital ₹ 2.50 M
as on 23-10-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 32.79 Cr
as on 23-10-2024
- Revenue -34.37%
(FY 2023)
- Profit -167.04%
(FY 2023)
- Ebitda -17.19%
(FY 2023)
- Net Worth -4.46%
(FY 2023)
- Total Assets -2.33%
(FY 2023)
About Rml Mehrotra Pathology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹32.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Mehrotra and Bandana Mehrotra serve as directors at the Company.
- CIN/LLPIN
U51397UP2005PTC029813
- Company No.
029813
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rml Mehrotra Pathology Private Limited offer?
Rml Mehrotra Pathology Private Limited offers a wide range of products and services, including Medical Treatment Services, Gastroenterology Services, Health Care Service, Rheumatology Service, Medical Consultancy Services, Microbiology Services, Nephrology Treatment, Medical Surgery & Treatment Centres, Diagnostic Imaging & Pathology Labs, Medical Test Services.
Who are the key members and board of directors at Rml Mehrotra Pathology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Mehrotra  | Director | 11-Apr-2005 | Current |
| Bandana Mehrotra | Director | 11-Apr-2005 | Current |
Financial Performance of Rml Mehrotra Pathology.
Rml Mehrotra Pathology Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.37% decrease. The company also saw a substantial fall in profitability, with a 167.04% decrease in profit. The company's net worth dipped by a decrease of 4.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rml Mehrotra Pathology?
In 2023, Rml Mehrotra Pathology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rml Quality Assurance Private LimitedActive 1 year 3 monthsSanjay Mehrotra and Bandana Mehrotra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Sep 2023 | ₹15.00 Cr | Open |
Hdfc Bank Limited Creation Date: 20 May 2021 | ₹12.96 Cr | Satisfied |
Yes Bank Limited Creation Date: 05 Aug 2019 | ₹3.50 M | Satisfied |
How Many Employees Work at Rml Mehrotra Pathology?
Rml Mehrotra Pathology has a workforce of 25 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rml Mehrotra Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rml Mehrotra Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
